Antihypertensive Drugs Flashcards
Major groups of antihypertensive drugs
Diuretics (thiazide, loop, potassium-sparing), sympatholytic, angiotensin inhibitors and vasodilators
Thiazide and related diuretics - MoA
Mechanism of decrease BP stems from their ability to increase sodium and water excretion.
When they are first administrated, the drug decreases blood volume and thereby decreases cardiac output. When adm is continued over weeks and months they also decrease peripheral vascular resistance (PVR), and this appear to account for much of their long term antihypertensive effect. The decrease PVR may result from a reduction in the sodium content of arteriolar smooth muscle cells, which decrease muscle contraction in response to vasopressor agents such as norepinephrine and angiotensin.
Thiazide and related diuretics - Adverse effects
Hypokalemia –> cardiac arrhythmias and muscle weakness.
Elevate plasma levels of: glucose, uric acid and lipids in some pat.
Hematologic toxicity
Aggravate hepatic disease and diabetes
Compensatory increase in renin secretion
Blood cell deficiencies
Thiazide and related diuretics - Interactions
Increase serum levels of lithium. Hypotensive effect decreased by NSAIDs and augmented by ACE inh.
Thiazide diuretics
Hydrochlorothiazide
Indapamide
Chlorthalidone
Hydrochlorothiazide - Indication
Initial treatment of persons with mild to moderate hypertension.
Thiazide diuretic most often used to treat hypertension.
Indapamide - Indication and benefit
Hypertension and the risk of stroke and MI.
Causes vasodilation via calcium channel blockade
Loop diuretics - MoA
Greater natriuretic effect.
Less effective than thiazide, they are reserved for use in hypertensive pat who have poor renal function and serum creatinine level greater than 2,3mg/dL.
Potassium - sparing diuretics - MoA
Mild natriuretic effect and they reduce renal potassium excretion –> prevent hypokalemia by thiazide drugs/ loop diuretics
Potassium - sparing diuretics - Adverse effects
Hyperkalemia
Potassium - sparing diuretics - Interactions
Hyperkalemic effect increased by ACE inh and potassium supplements.
Potassium - sparing diuretics
Amiloride
Spironolactone
Eplerenone
Triamterene
Spironolactone and Eplerenone - Indication
Hypertension that cannot be controlled with combinations of three or more other agents.
Alpha-adrenoceptor antagonists
Doxazosin
Prazosin
Terazosin
Alpha-adrenoceptor antagonists - MoA
Effectively inhibit sympathetic stimulation of arteriolar contraction –> vasodilation and decrease vascular resistance, BUT several disadvantages.
Alpha-adrenoceptor antagonists - Indication
Not recommended for the initials treatment of hypertension, but can be added with other drugs when BP is not adequately controlled.
Alpha-adrenoceptor antagonists - Adverse effect
Reflex activation of SNS: increased HR, contractile force, circulating NE --> increased myocardial oxygen requirements Orthostatic hypotension “first dose” syncope Dizziness Fluid retention
Alpha-adrenoceptor antagonists - Interactions
Hypotensive effect increased by beta-blockers and potassium supplements.
Beta-Adrenoceptor antagonists
Nonselective: Nadolol Pindolol Propranolol Timolol Selective: Atenolol Esmolol Nebivolol Mixed alpha and beta: Carvedilol and labetalol
Beta-Adrenoceptor antagonists - MoA
Blockade of beta1 receptors reduces cardiac output by decreasing the heart rate and contractility. Block of these receptors in renal juxtaglomerular cells inhibit renin secretion –> reduces the formation of Angiotensin II and the release of Aldosterone.
The drugs also appear to reduce sympathetic outflow from the central nervous system.
Beta-Adrenoceptor antagonists - Indication
Beneficial in hypertensive persons with other cardiovascular diseases. In coronary heart disease- reduce myocardial ischemia and lower risk of MI.
In persons with previous MI they are cardioprotective- prevent sudden death, by decreasing HR and the risk of ventricular arrhythmias.
In heart failure: improves symptoms and survival.
Beta-Adrenoceptor antagonists - Adverse effects
Fatigue, depression, vivid dreams, decreased exercise capacity
Bradycardia
Bronchoconstriction
Impaired glycogenolysis
Beta-Adrenoceptor antagonists - Contraindications and Interactions
Contraindications:
Nonselective: Contraindicated in pt with asthma or COPD
In diabetics, delay recovery from hypoglycemia by blocking glycogenolysis and mask symptoms of hypoglycemia.
Interactions:
Cardiac depression increased by diltiazem and verapamil.
Hypotensive effect decreased by NSAID
Labetalol - Indication
Treats both chronic hypertension and hypertensive emergencies.
Carvedilol and Labetalol - Adverse effects
Orthostatic hypotension
Esmolol - Indications
Treat hypertension in surgical procedures and in persons with hypertensive emergencies.
Nebivolol - Indications
Hypertension in pat with heart failure, diabetes and cardiac arrhythmias.